International CML Foundation

Website

International CML Foundation Improving outcomes for patients with CML globally. Join us and contribute to a world where a cure for CML is not just a hope, but a reality.

The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.

Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.

As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and caregivers alike, in the collective pursuit of a cure.

19/11/2026

Join us in celebrating Professor Junia Vaz de Melo, recipient of the 2026 iCMLf Rowley Prize!

The award recognises her lifetime contributions to advancing the biological understanding of CML. Over several decades, Professor Vaz de Melo has made important discoveries towards elucidation of the molecular mechanisms underlying CML, leading to the translation of these insights into improved strategies for diagnosis and treatment.

In this clip, she recalls the phone call from John Goldman that led her to become a “CML lady”.

🎥 Watch her keynote presentation from the ESH-iCMLf 28th Annual John Goldman Conference: https://buff.ly/x66cEjf

🔊 Happening today: the last 2026 iCMLf Regional Discussion Group meeting for physicians across Africa!Together we'll exp...
18/11/2026

🔊 Happening today: the last 2026 iCMLf Regional Discussion Group meeting for physicians across Africa!

Together we'll explore:
✅ Treatment pathways for advanced-phase CML diagnosis, tailored to the African context
✅ Overcoming challenges to treatment adherence

Join experts Professor Jerry Radich, Dr Delphine Rea, Dr Siddeeq Hoosen and Dr Patricia Da Silva for an engaging discussion and live Q&A.

📆 Today! Wednesday, 18 November 2026
🔗 Register now: https://buff.ly/K5HQmVv

The iCMLf Knowledge Centre continues to grow in 2026, and we are pleased to share our third new module: New Therapies. T...
13/11/2026

The iCMLf Knowledge Centre continues to grow in 2026, and we are pleased to share our third new module: New Therapies.

The module brings together presentations including "Advances in CML treatment: ponatinib and asciminib" by Dr Delphine Rea, and "Combination Therapy for CML in all phases: What's new?" by Professor Michael Mauro.

Watch the module here: https://buff.ly/vakarHN

The iCMLf Knowledge Centre is a comprehensive online resource designed to support healthcare professionals, scientists, and others involved in CML care and research worldwide.

We’re delighted to share that our abstract, "Frontline therapy with tyrosine kinase inhibitors (TKIs) may modify the fre...
12/11/2026

We’re delighted to share that our abstract, "Frontline therapy with tyrosine kinase inhibitors (TKIs) may modify the frequency of mutated ASXL1 and the cell lineage in blast phase (BP) CML: Insights from the International CML Foundation (iCMLf) Genomics Alliance on the HARMONY Platform" (Branford S et al., ID 95), has been accepted for the ASH Annual Meeting 2026.

Professor Susan Branford will present in the Oral Abstract Session "Chronic myeloid leukemia: Clinical and epidemiological: Biomarkers, resistance and molecular frontier."

📆 Saturday, December 12th, 9.30am-11.00am (local time in New Orleans)
📍 Room: MMCNO - Hall B.

Congratulations to Professor Branford and all collaborators involved in this achievement from the iCMLf/HARMONY Genomics project.

📆 It’s not too late to join the final 2026 Regional Discussion Group for physicians across Africa, on 18th November.Join...
11/11/2026

📆 It’s not too late to join the final 2026 Regional Discussion Group for physicians across Africa, on 18th November.

Join experts Professor Jerry Radich, Dr Delphine Rea, Dr Siddeeq Hoosen and Dr Patricia Da Silva for a practical discussion that combines global expertise with local insight. Simultaneous interpretation available in French.

Register now: https://buff.ly/SZR1YyA

Have you checked out the CML Monitoring and Treatment Pathways Beyond 2026 module in the iCMLf Knowledge Centre?Our Know...
10/11/2026

Have you checked out the CML Monitoring and Treatment Pathways Beyond 2026 module in the iCMLf Knowledge Centre?

Our Knowledge Centre has grown in 2026, with three new modules covering important areas of CML management and research.

The CML Monitoring and Treatment Pathways Beyond 2026 module brings together video presentations on topics ranging from the role of next generation sequencing in CML management, future monitoring systems and the future of TFR.

Visit the module and take a look at the available presentations: https://buff.ly/48cgqvx

Here is our selection of CML papers for October, curated this month by Professor Tim Hughes. 1️⃣ Predictive biomarkers o...
09/11/2026

Here is our selection of CML papers for October, curated this month by Professor Tim Hughes.

1️⃣ Predictive biomarkers of sustained treatment-free remission in chronic myeloid leukemia: gene expression analysis from the ENESTfreedom and ENESTop studies, Radich J et al. Haematologica, October 2026
Open access publication: https://buff.ly/l3Qjmtx

2️⃣ Prominin-1 (CE133) is essential for the determination of the phenotype of Philadelphia chromosome-positive leukemias, Metodieva A et al. Exp Hematol, Oct 2026 (epub ahead of print)
Open access publication: https://buff.ly/MyIu34Y

3️⃣ A rare BCR::SPECC1L::ABL1 fusion in a pediatric chronic myeloid leukemia patient, Cubuk E et al. J Pediatr Hematol Oncol, October 2026
https://buff.ly/QxOX077

4️⃣ Twenty-five years of chronic myeloid leukemia therapy in India: A model for precision oncology in a resource-constrained setting, Chaukan P et al. Clin Lymphoma Myeloma Leuk, October 2026 (epub ahead of print)
https://buff.ly/9O5y1nk

📖 Explore the full list of papers on our website: https://buff.ly/HWqeU1o

Did you know our iCMLf Knowledge Centre has grown in 2026? One of the three new modules added this year is New Research,...
05/11/2026

Did you know our iCMLf Knowledge Centre has grown in 2026?

One of the three new modules added this year is New Research, bringing together talks on CML stem cells, TKI resistance, molecular biology, immunology and immunotherapy, and AI in CML.

Expert insights on CML, just a click away. View module: https://buff.ly/38b3jyE

The iCMLf Knowledge Centre is a comprehensive online resource designed to support healthcare professionals, scientists, and others involved in CML care and research worldwide.

What happens when guidelines meet the realities of everyday practice?The third iCMLf Saudi Arabian Regional Discussion G...
04/11/2026

What happens when guidelines meet the realities of everyday practice?

The third iCMLf Saudi Arabian Regional Discussion Group looked at two closely linked themes: quality of life for people living with CML, and managing CML in young adults.

From managing treatment intolerance to supporting younger patients with adherence, TFR and pregnancy, the discussions emphasised the need to adapt CML management to each patient’s comorbidities, priorities and circumstances.

📄 Read the report now: https://buff.ly/1z4ueNk

03/11/2026

It’s been three weeks since the John Goldman Fun Run in Gothenburg, and we still can’t get over it! Around 50 runners and walkers came together for a fantastic morning, raising a record US$3,333 for the Foundation’s mission to improve outcomes for people living with CML 💜

A heartfelt thank you to François-Xavier Mahon for capturing the spirit of the Fun Run in this video! 📹

Address

Bexhill

Alerts

Be the first to know and let us send you an email when International CML Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share